Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

2nd PCNE Working Conference 2001, Hillerød, Denmark

Quality Issues in Pharmaceutical Care Research

24-28 January 2001


The proceedings from this conference have been published, in combination with the proceedings of the 3rd Working Conference. ISBN 90-808817-1-6

 

Philosophy is turning into reality. This might be a suitable motto to characterise the development of pharmaceutical care over the past few years. We are aware that this motto may be too ambitious, but it reflects the enthusiasm and the efforts of researchers and pharmacists aiming to contribute to better health care.
"Better health care" is a phrase that can easily be used as the keyword for this 2nd International Working Conference on Quality Issues in Pharmaceutical Care Research. The focus of the previous and first working conference in 1999 was on developing instruments to measure outcomes in pharmaceutical care. As developing instruments can be seen as a prerequisite to conduct research into pharmaceutical care, this time we would like to motivate you to take the next steps.
We learned from several studies that quality is a core aspect in the field of pharmaceutical care, not only regarding the classical categorisation into structure, process, and outcome quality but more as a holistic concept. Therefore, we have compiled an agenda which addresses quality issues in several domains: pharmacoepidemiology, health economics, organisational theories, patient satisfaction, the intervention process, drug use indicators, and pharmaceutical care trials.
The problems we are confronted with are as diverse as the topics mentioned. Our working conference is the appropriate framework to stimulate research in these fields, to devise new strategies, and to look for problemsolving strategies. Here in Hillerød, researchers and activists share their insights and experiences. The format of this working conference relies on extensive and in-depth discussions among bóth, participants and workshop leaders/speakers.
The general objectives of our working conference are:

  • To contribute to the development of high quality pharmaceutical care research
  • To expand the knowledge and insights in pharmaceutical care research
  • To provide a multi-faceted view on pharmaceutical care research
  • To further establishing a sound methodological and scientific basis for pharmaceutical care.

However, meeting old friends and finding new ones -having fun -is equally important. So, PCNE and Pharmakon have made appropriate arrangements to improve your quality of life.

 

Martin Schulz, PCNE Chairman

 

Organising committee: Martin Schulz (Chair, Germany), Bente Frøkjaer (Secretary, Denmark), Inigo Gorostiza (Spain), Marleen Haems (Belgium), Martin Henman (Ireland), Hanne Herborg (Denmark), Mitja Kos (Slovenia), Foppe van Mil (the Netherlands).

- What happened with the results of the 1999 conference? Foppe van Mil, the Netherlands

- Pharmaceutical Care and Medicines Management, is there a difference? Nich Barber, United Kingdom

- From laboratory to pharmaceutical care research. Mark Mobach, the Netherlands

- No money - no fun. Health economics within pharmaceutical care research. Dale Christensen, USA

- Interaction between pharmaceutical care and pharmacoepidemiology - un unexploited research agenda? Bert Leufkens, the Netherlands

- Satisfaction - How can we measure change? Hanne Herborg, Denmark

Workshop 1: Studying the intervention process (Dale Christensen, USA & Hanne Herborg, Denmark)

Workshop 2: Applying health status instruments in pharmaceutical care research (Foppe van Mil, the Netherlands & Martin Henman, Ireland)

Workshop 3: Developing Drug (Mis-) use indicators (Nich Barber, Great Britain & Marion Schaefer, Germany)

Workshop 4: Assessing changes in drug use (Bert Leufkens, the Netherlands & Birthe Søndergaard, Denmark)

Workshop 5: Designing an optimal pharmaceutical care study (Carmel Hughes, N. Ireland & Frank Verheyen, Germany)